Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited) (Parenthetical)

v3.23.1
Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
shares in Thousands, $ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Allowance for accounts receivable $ 2,124 $ 2,164
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 180,000 180,000
Common stock, shares issued 26,329 7,723
Common stock, shares outstanding 26,327 7,721